Robot-aided Therapy in Stroke Patients for Upper Limb Rehabilitation (MITEEG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01658111|
Recruitment Status : Unknown
Verified August 2012 by Patrizio Sale , MD, IRCCS San Raffaele.
Recruitment status was: Recruiting
First Posted : August 6, 2012
Last Update Posted : September 3, 2012
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Device: Robot Group Procedure: Traditional physiotherapy||Not Applicable|
The main original contribution of this project is to provide an experimental framework, based on proximal robotic treatment approach, to test whether starting with the distal robot-assisted sensorimotor therapy the effective in improving motor functions of sub-acute stroke patients.
The use of robotic platforms to administer the rehabilitation therapy is crucial for two main reasons:
- the physical therapies based on robotic platforms assure that each patient in the same testing group is treated in the same repeatable way, eliminating the intrinsic subject-dependent variability that affects traditional therapies;
- the robotic platforms, in conjunction with EEG and EMG recordings, can be used to assess the effects of the rehabilitative treatments in a quantitative, measurable way, by providing reliable and objective methods for measuring functional recovery after stroke.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Official Title:||Robot-aided Therapy in Acute Stroke Patients for the Upper Limb Rehabilitation With Long-term Follow-up.|
|Study Start Date :||July 2012|
|Estimated Primary Completion Date :||July 2013|
|Estimated Study Completion Date :||August 2014|
Active Comparator: Traditional physiotherapy
Each subject will receive 4 weeks of traditional upper limb rehabilitation treatment (20 sessions, 5 days a week for 4 weeks).
Procedure: Traditional physiotherapy
Active or passive exercises.
Other Name: FKT
Experimental: Robot Group
Each subject will be asked to perform five sessions per week goal-directed, planar reaching tasks, which emphasizes shoulder and elbow movements, moving from the centre target to each of 8 peripheral targets equally spaced on a 0.14 m radius circumference around a centre target using the InMotion2 (IM2) system (20 sessions- 5 days a week for 4 weeks).
Device: Robot Group
The MIT-MANUS/InMotion2 (Interactive Motion Technologies, Inc., Watertown, MA, USA) system has two translational degrees of freedom (dof): shoulder abduction-adduction (ab-ad), elbow flexion-extension (flexext).
The robotic system supports the execution of reaching movements in the horizontal plane through an assist as needed control strategy. The robot can guide the movement of the upper limb of the patients and record end-effector physical quantities such as the position, velocity, and applied forces. The device is designed to have a low intrinsic end-point impedance (i.e., be back-drivable to easily carry the weight of the patient's arm, to execute movements without constraint and offer minimal resistance. A 3-dof force transducer is placed at the robots end-effector, as well.
Other Name: MIT-MANUS/InMotion2
- Change from Baseline in Fugl-Meyer Scale at 28 weeks. [ Time Frame: at inclusion, week 4 and week 28 ]
- Change from Baseline in Box and Block Test at 28 weeks. [ Time Frame: at inclusion, week 4 and week 28. ]
- Change from Baseline in Modified Ashworth Scale at 28 weeks. [ Time Frame: at inclusion, week 4 and week 28. ]
- Change from Baseline in Frenchay Arm Test at 28 weeks. [ Time Frame: at inclusion, week 4 and week 28. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01658111
|Contact: Patrizio Sale, MDfirstname.lastname@example.org|
|Contact: Marco Francescini, MDemail@example.com|
|IRCCS San Raffaele Pisana||Recruiting|
|Roma, Italy, 00161|
|Contact: Patrizio Sale, MD firstname.lastname@example.org|
|Contact: Marco Franceschini, MD email@example.com|
|Principal Investigator: Patrizio Sale, MD|
|Sub-Investigator: Marco Franceschini, MD|
|Auxilium Viate Volterra||Recruiting|
|Contact: Federico Posteraro, MD firstname.lastname@example.org|
|Contact: Stefano Mazzoleni, Phd email@example.com|
|Principal Investigator: Federico Posteraro, MD|
|Sub-Investigator: Stefano Mazzoleni, PhD|
|Principal Investigator:||Patrizio Sale, MD||IRCCS San Raffaele Pisana Rome|